INTRODUCTION
Complete heart block (third-degree atrioventricular block) is a defect of the conduction system of the heart, in which the impulse generated in the sinoatrial node does not propagate to the ventricles, and thus the latter contract independently of the atria. A third-degree atrioventricular block can be either congenital or acquired. In 60-70% of the cases, the congenital heart block results from destruction of the conduction system of the fetal heart by anti-Ro/SSA and anti-La/SSB antibodies present in maternal serum. The antibodies are synthesized in the course of autoimmune maternal conditions, most often systemic lupus erythematosus or rarer rheumatoid arthritis, dermatomyositis or Sjögren's syndrome. The complete block can occur as an isolated defect or be associated with structural anomalies of the fetal heart.
MATERIAL AND METHODS
A total of five patients whose fetuses were diagnosed with the third-degree atrioventricular block have been hospitalized at the Department of Obstetrics, Medical University of Gdansk between 2012 and 2014.
RESULTS
We present the data of the five patients, hospitalized at the Department of Obstetrics, Medical University of Gdansk, whose fetuses were diagnosed prenatally with the complete heart block. The cases differ in terms of etiology clinical outcome, and postnatal treatment. All data are presented in Table I.
CONCLUSIONS
We emphasize the role of appropriate pregnancy management and careful monitoring of the fetal condition. From obstetrical perspective, it is important to monitor the condition of fetuses with the third-degree atrioventricular block ultrasonographically and echocardiographically; in turn, cardiotocography is less useful in this setting. Therefore, a non-reactive cardiotocographic tracing should not constitute an indication for a preterm delivery. An affected fetus should be delivered in a tertiary center for perinatal care that cooperates with a pediatric cardiology center. An efficient program for cardologic prenatal care and close cooperation between obstetricians, neonatologists, pediatric cardiologists, and cardiac surgeons constitute the key to a successful outcome.
[1]
K. Leszczynska,et al.
“Planned” permanent pacemaker implantation in one-day-old newborn after prenatal diagnosis of congenital complete atrioventricular heart block
,
2014,
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery.
[2]
E. Cicinelli,et al.
Antenatal and postnatal combined therapy for autoantibody-related congenital atrioventricular block
,
2013,
BMC Pregnancy and Childbirth.
[3]
A. Yildirim,et al.
Neonatal congenital heart block
,
2013,
Indian Pediatrics.
[4]
John M. Simpson,et al.
Isolated Atrioventricular Block in the Fetus: A Retrospective, Multinational, Multicenter Study of 175 Patients
,
2011,
Circulation.
[5]
E. Jaeggi,et al.
The Benefits of Transplacental Treatment of Isolated Congenital Complete Heart Block Associated with Maternal Anti‐Ro / SSA Antibodies: A Review
,
2010,
Scandinavian journal of immunology.
[6]
Y. Dulac,et al.
[Fetal myocarditis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block with good outcome].
,
2010,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[7]
T. Kuwata,et al.
Resumption of sinus rhythm from fetal complete atrioventricular block after maternally administered ritodrine
,
2010,
Archives of Gynecology and Obstetrics.
[8]
E. Jaeggi,et al.
Maternal autoimmune disease and its impact on the fetal heart: Management and prognosis
,
2006
.
[9]
E. Rosenthal,et al.
Outcome of isolated congenital complete heart block diagnosed in utero.
,
1996,
Heart.